On November 5, 2019 Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will reported its financial results for the first nine months of 2019 on Tuesday, 12 November 2019 (Press release, Evotec, NOV 5, 2019, View Source;announcements/press-releases/p/evotec-se-to-announce-results-for-the-first-nine-months-2019–on-12-november-2019-5860 [SID1234550286]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The Company is going to hold a conference call to discuss the results as well as to provide an update on its performance. The conference call will be held in English.
Conference call details
Date: Tuesday, 12 November 2019
Time: 02.00 pm CET (08.00 am EST, 01.00 pm GMT)
From Germany: +49 69 20 17 44 220
From France: +33 170 709 502
From Italy: +39 023 600 6663
From UK: +44 20 3009 2470
From USA: +1 877 423 0830
Access Code: 25877742#
A simultaneous slide presentation for participants dialling in via phone is available at View Source